Villalona-Calero MA - Search Results

1

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.

Heist RS, Wang X, Hodgson L, Otterson GA, Stinchcombe TE, Gandhi L, Villalona-Calero MA, Watson P, Vokes EE, Socinski MA; Alliance for Clinical Trials in Oncology. Heist RS, et al. J Thorac Oncol. 2014 Feb;9(2):214-21. doi: 10.1097/JTO.0000000000000071. J Thorac Oncol. 2014. PMID: 24419419 Free PMC article. Clinical Trial.

2

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF).

Vaickus L, Villalona-Calero MA, Caligiuri T. Vaickus L, et al. Leukemia. 1993 Oct;7(10):1680-1. Leukemia. 1993. PMID: 7692195 No abstract available.

3

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.

Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA. Zhu WG, et al. Oncogene. 2001 Nov 22;20(53):7787-96. doi: 10.1038/sj.onc.1204970. Oncogene. 2001. PMID: 11753657

4

Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.

Nadella P, Shapiro C, Otterson GA, Hauger M, Erdal S, Kraut E, Clinton S, Shah M, Stanek M, Monk P, Villalona-Calero MA. Nadella P, et al. J Clin Oncol. 2002 Jun 1;20(11):2616-23. doi: 10.1200/JCO.2002.22.030. J Clin Oncol. 2002. PMID: 12039922 Clinical Trial.

5

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

Rudin CM, Otterson GA, Mauer AM, Villalona-Calero MA, Tomek R, Prange B, George CM, Szeto L, Vokes EE. Rudin CM, et al. Ann Oncol. 2002 Apr;13(4):539-45. doi: 10.1093/annonc/mdf124. Ann Oncol. 2002. PMID: 12056703 Free article. Clinical Trial.

6

RT-PCR heteroduplex analysis permits differentiation of transgene and host gene expression in a transgenic animal model.

Duan W, Ding H, Zhu WG, Srinivasan K, Otterson GA, Villalona-Calero MA, Ottersom GA. Duan W, et al. Biotechniques. 2002 Jul;33(1):58, 60-2, 64 passim. doi: 10.2144/02331st02. Biotechniques. 2002. PMID: 12139258 Free article.

7

Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

Duan W, Ding H, Subler MA, Zhu WG, Zhang H, Stoner GD, Windle JJ, Otterson GA, Villalona-Calero MA. Duan W, et al. Oncogene. 2002 Nov 7;21(51):7831-8. doi: 10.1038/sj.onc.1205909. Oncogene. 2002. PMID: 12420220

8

P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.

Ding H, Duan W, Zhu WG, Ju R, Srinivasan K, Otterson GA, Villalona-Calero MA. Ding H, et al. Biochem Biophys Res Commun. 2003 Jun 13;305(4):950-6. doi: 10.1016/s0006-291x(03)00873-8. Biochem Biophys Res Commun. 2003. PMID: 12767922

9

Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.

Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA. Zhu WG, et al. Mol Cell Biol. 2003 Jun;23(12):4056-65. doi: 10.1128/MCB.23.12.4056-4065.2003. Mol Cell Biol. 2003. PMID: 12773551 Free PMC article.

10

Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.

Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL. Villalona-Calero MA, et al. Clin Cancer Res. 2003 Aug 15;9(9):3303-11. Clin Cancer Res. 2003. PMID: 12960116 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters